- Previous Close
11.35 - Open
11.38 - Bid 10.81 x --
- Ask 10.82 x --
- Day's Range
10.75 - 11.48 - 52 Week Range
10.75 - 24.00 - Volume
920,311 - Avg. Volume
555,788 - Market Cap (intraday)
1.467B - Beta (5Y Monthly) 2.08
- PE Ratio (TTM)
9.92 - EPS (TTM)
1.09 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
24.97
Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid; and in Phase 2 clinical trial for the treatment of Angelman and Pitt Hopkins. In addition, it develops NNZ-2591, which is in Preclinical trial stage for the treatment of Prader-Willi syndrome. The company was incorporated in 2001 and is based in Camberwell, Australia.
www.neurenpharma.comRecent News: NEU.AX
View MorePerformance Overview: NEU.AX
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NEU.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NEU.AX
View MoreValuation Measures
Market Cap
1.47B
Enterprise Value
1.24B
Trailing P/E
10.45
Forward P/E
66.67
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.96
Price/Book (mrq)
4.03
Enterprise Value/Revenue
5.84
Enterprise Value/EBITDA
7.09
Financial Highlights
Profitability and Income Statement
Profit Margin
65.51%
Return on Assets (ttm)
34.05%
Return on Equity (ttm)
49.92%
Revenue (ttm)
216.83M
Net Income Avi to Common (ttm)
142.04M
Diluted EPS (ttm)
1.09
Balance Sheet and Cash Flow
Total Cash (mrq)
222.24M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-42.25M